{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:31:14Z","timestamp":1771723874993,"version":"3.50.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182154","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T13:37:54Z","timestamp":1503409074000},"page":"e0182154","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals"],"prefix":"10.1371","volume":"12","author":[{"given":"Naseem","family":"Cassim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindi Marie","family":"Coetzee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Schnippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-769X","authenticated-orcid":true,"given":"Deborah Kim","family":"Glencross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jinf.2010.03.015","article-title":"The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts","volume":"60","author":"P Pongsai","year":"2010","journal-title":"J Infect"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7196\/SAMJ.4752","article-title":"Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts\u2014time to implement in South Africa?","volume":"101","author":"JN Jarvis","year":"2011","journal-title":"S Afr Med J"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study","volume":"62","author":"N Longley","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref4","article-title":"Evaluation of a Public-sector, Provider-initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa","author":"S Vallabhaneni","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/17530059.2012.681300","article-title":"CrAg lateral flow assay for cryptococcosis","volume":"6","author":"TR Kozel","year":"2012","journal-title":"Expert Opin Med Diagn"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"e0171675","DOI":"10.1371\/journal.pone.0171675","article-title":"Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells\/mul using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa","volume":"12","author":"N Cassim","year":"2017","journal-title":"PloS one"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1371\/journal.pone.0158986","article-title":"Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa","volume":"11","author":"BA Larson","year":"2016","journal-title":"Plos One"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"e114727","DOI":"10.1371\/journal.pone.0114727","article-title":"An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme","volume":"9","author":"DK Glencross","year":"2014","journal-title":"PloS one"},{"key":"ref9","unstructured":"National Department of Health (NDOH). HIV & AIDS 2014\/15 Data Fact Sheet. 7th South African AIDS Conference; Durban\/South Africa2015."},{"key":"ref10","unstructured":"National Department of Health (NDOH). National consolidated Guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria, South Africa: 2015."},{"key":"ref11","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). 90-90-90. An ambitious treatment target to help end the AIDS epidemic. 2014."},{"key":"ref12","article-title":"Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach","year":"2016"},{"key":"ref13","unstructured":"Govender N.P. MG, Bicanic T.,Dawood H.,Harrison T.S.,Jarvis J.N., Karstaedt A.S.,Maartens G.,McCarthy K.M., Rabie H.,Variava E.,Venter W.D.F.,Boulware D.R.,Chiller T.,Meya D.B. & Scriven J. Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update. Southern African HIV Clinicians Society; 2013."},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/CVI.00446-12","article-title":"Comparison of four assays for the detection of cryptococcal antigen","volume":"19","author":"MJ Binnicker","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref15","unstructured":"Standard Bank of South Africa (SBSA). Forex closing indication rates for 17 July 2016 as at 16:08 2015."},{"key":"ref16","unstructured":"Santerre RE, Neun SP. Health Economics: Theory, Insights, and Industry Studies. Mason, Ohio: South Western; 2013."},{"key":"ref17","unstructured":"Cassim Naseem CLM, Moodley Keshendree, Schnippel Kathryn, Govender Nelesh P, Glencross Deborah Kim. Incremental costs of implementing automated EIA for cryptococcal antigenaemia detection compared to a lateral flow assay at a high-volume public-sector laboratory in South Africa. 8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-poor Settings; Lusaka, Zambia2015."},{"key":"ref18","unstructured":"Department of Public Service and Administration (DPSA). Circular 3 of 2016 Pretoria, South Africa: Department of Public Service and Administration (DPSA); 2016. http:\/\/www.naptosagp.org.za\/index.php\/documents-02\/90-news-flashes\/913-gauteng-news-flashes-2016\/432-gp-nf-20-of-2016-salary-increase-for-nurses-1-april-2016\/file<\/ext-link>."},{"key":"ref19","unstructured":"World Health Organisation (WHO). Rapid Advice: Diagnosis, Prevention and Management of Cryptococc al Disease in HIV -infected Ad ults, Adolescents and Children Geneva, Switzerland2011. www.who.int\/hiv\/pub\/cryptococcal_disease2011\/en\/<\/ext-link>"},{"key":"ref20","unstructured":"Moodley K, Coetzee LM, Shimp E, Neary B, Crider B, Glencross DK. Preliminary data on a new flow cytometry assay for the early detection of Cryptococcal Antigenaemia. ASLM2014; Cape Town, South Africa2014."},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"e115420","DOI":"10.1371\/journal.pone.0115420","article-title":"Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa","volume":"9","author":"N Cassim","year":"2014","journal-title":"PloS one"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e35444","DOI":"10.1371\/journal.pone.0035444","article-title":"How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa","volume":"7","author":"B Larson","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.7196\/SAMJ.2016.v106i1.10081","article-title":"Implementation of a new 'community' laboratory CD4 service in a rural health district in South Africa extends laboratory services and substantially improves local reporting turnaround time","volume":"106","author":"LM Coetzee","year":"2015","journal-title":"S Afr Med J"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4102\/sajhivmed.v16i1.428","article-title":"Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy","volume":"16","author":"G Meintjes","year":"2015","journal-title":"S Afr J HIV Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:18:54Z","timestamp":1540030734000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182154"}},"subtitle":[],"editor":[{"given":"Maureen J.","family":"Donlin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182154","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}